SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark Pharmaceuticals informs about board meeting

16 Oct 2015 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on October 29, 2015, to consider and approve the Company’s Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2015 (Q2). Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, the trading window closed for Directors and other designated employees of the Company on September 24, 2015 and will remain closed up to November 02, 2015 for the purpose of approval of Unaudited Financial Statements for the Second Quarter/Half Year ended September 30, 2015.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×